Kenvue Inc. logo

Kenvue Inc. (KVUE)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
16. 93
-0.06
-0.35%
$
33B Market Cap
21.62 P/E Ratio
0.8% Div Yield
21,022,200 Volume
1.14 Eps
$ 16.99
Previous Close
Day Range
16.82 17.09
Year Range
14.02 25.17
Want to track KVUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 61 days
Is Kenvue Stock a Buy Now?

Is Kenvue Stock a Buy Now?

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.

Fool | 1 year ago
Starboard says Kenvue's skin health segment is weighing on performance

Starboard says Kenvue's skin health segment is weighing on performance

Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance.

Reuters | 1 year ago
3-Stock Lunch: Kenvue, UPS & Disney

3-Stock Lunch: Kenvue, UPS & Disney

Sylvia Jablonski, Defiance ETF co-founder, joins 'Power Lunch' to discuss stock plays for three stocks.

Youtube | 1 year ago
Investor Hoping To "Band-Aid" KVUE Stock Price

Investor Hoping To "Band-Aid" KVUE Stock Price

The Wall Street Journal reported that Starboard Value has taken a "sizeable" stake in Kenvue (KVUE) with hopes of matching the company's stock price to competitors. Despite having Tylenol and Band-Aid as part of its brand portfolio, George Tsilis looks at the headwinds facing Kenvue's growth.

Youtube | 1 year ago
Kenvue gains on reports activist investor Starboard Value has taken ‘sizeable' stake

Kenvue gains on reports activist investor Starboard Value has taken ‘sizeable' stake

Kenvue Inc (NYSE:KVUE) shares moved more than 6% higher on reports activist investor Starboard Value has taken a stake in the consumer goods company and is eyeing changes. A person familiar with the matter told the Wall Street Journal that Starboard's stake in the Tylenol-maker is “sizeable.

Proactiveinvestors | 1 year ago
Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'

Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'

Shares of Kenvue (KVUE) took off Monday morning on indications activist investor Starboard Value has taken a large stake in the consumer health products maker.

Investopedia | 1 year ago
Kenvue shares surge after activist Starboard takes stake

Kenvue shares surge after activist Starboard takes stake

Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023, according to people familiar with the matter. Starboard's Jeff Smith is expected to detail the position further at 13D Monitor's Active-Passive Investor Summit on Tuesday.

Cnbc | 1 year ago
Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.

Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.

Tylenol, Listerine and Band-Aid maker Kenvue has attracted the activist investor, according to a report.

Barrons | 1 year ago
Starboard reportedly takes big stake in Tylenol maker Kenvue

Starboard reportedly takes big stake in Tylenol maker Kenvue

Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night.

Marketwatch | 1 year ago
Activist investor Starboard Value takes stake in consumer products maker Kenvue, sources say

Activist investor Starboard Value takes stake in consumer products maker Kenvue, sources say

Activist investor Starboard Value has a stake in Kenvue , which makes Listerine and Tylenol, two sources familiar with the matter told Reuters on Sunday.

Reuters | 1 year ago
Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue

Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make changes to boost its share price.

Wsj | 1 year ago
Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for

Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Loading...
Load More